The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04448886
Brief Title: Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC
First Submitted : June 24, 2020
First Submitted that Met QC Criteria : June 24, 2020
First Posted : June 26, 2020
Last Update Submitted that Met QC Criteria : March 21, 2024
Last Update Posted : March 25, 2024